Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
237M
-
Number of holders
-
125
-
Total 13F shares, excl. options
-
130M
-
Shares change
-
+10.3M
-
Total reported value, excl. options
-
$315M
-
Value change
-
+$25.7M
-
Put/Call ratio
-
0.27
-
Number of buys
-
68
-
Number of sells
-
-44
-
Price
-
$2.43
Significant Holders of ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) as of Q3 2022
144 filings reported holding ADMA - ADMA BIOLOGICS, INC. - COMMON STOCK as of Q3 2022.
ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) has 125 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 130M shares
of 237M outstanding shares and own 54.79% of the company stock.
Largest 10 shareholders include BlackRock Inc. (13M shares), PERCEPTIVE ADVISORS LLC (10.9M shares), STATE STREET CORP (9.42M shares), VANGUARD GROUP INC (9.29M shares), Nuveen Asset Management, LLC (8.7M shares), BOOTHBAY FUND MANAGEMENT, LLC (8.12M shares), D. E. Shaw & Co., Inc. (5.84M shares), Velan Capital Investment Management LP (5.27M shares), AWM Investment Company, Inc. (5.02M shares), and Stonepine Capital Management, LLC (5M shares).
This table shows the top 125 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.